Novel Biomarker MicroRNAs for Subtyping of Acute Coronary Syndrome: A Bioinformatics Approach

Abstract EN

Acute coronary syndrome (ACS) is a life-threatening disease that affects more than half a million people in United States.

We currently lack molecular biomarkers to distinguish the unstable angina (UA) and acute myocardial infarction (AMI), which are the two subtypes of ACS.

MicroRNAs play significant roles in biological processes and serve as good candidates for biomarkers.

In this work, we collected microRNA datasets from the Gene Expression Omnibus database and identified specific microRNAs in different subtypes and universal microRNAs in all subtypes based on our novel network-based bioinformatics approach.

These microRNAs were studied for ACS association by pathway enrichment analysis of their target genes.

AMI and UA were associated with 27 and 26 microRNAs, respectively, nine of them were detected for both AMI and UA, and five from each subtype had been reported previously.

The remaining 22 and 21 microRNAs are novel microRNA biomarkers for AMI and UA, respectively.

The findings are then supported by pathway enrichment analysis of the targets of these microRNAs.

These novel microRNAs deserve further validation and will be helpful for personalized ACS diagnosis.